The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

Authors of this article:

Liselot N van den Berg^{1, 2} ;   Cynthia Hallensleben^{1, 2} ;   Lisa AE Vlug^{1, 2} ;   Niels H Chavannes^{1, 2} ;   Anke Versluis^{1, 2}